Survival predictors in second-line chemotherapy for metastatic gastric cancer

被引：0
|
作者：
Bohanes, P. O. [1 ]
Courvoisier, D. [1 ]
Perneger, T. [1 ]
Morel, P. [1 ]
Huber, O. [1 ]
Roth, A. D. [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15575
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer
    Naito, Renato
    Izumi, Kouji
    Kadomoto, Suguru
    Makino, Tomoyuki
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Kadono, Yoshifumi
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1141 - 1146
  • [22] Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer
    Christoph C. Zielinski
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 33 - 36
  • [23] Second-line chemotherapy for metastatic/recurrent head and neck cancer
    Ferrari, D.
    Codeca, C.
    Caldiera, S.
    Zonato, S.
    Luciani, A.
    Fiore, J.
    Cossu-Rocca, M.
    Verri, E.
    Foa, P.
    ANNALS OF ONCOLOGY, 2007, 18 : 56 - 56
  • [24] Taxotere as second-line chemotherapy for metastatic breast cancer.
    Culine, S
    REVUE DE MEDECINE INTERNE, 1999, 20 (03): : 277 - 280
  • [25] Outcomes with second-line chemotherapy in castrate metastatic prostate cancer
    Beekman, KW
    Fleming, MT
    Scher, HI
    Warren, M
    Ishill, N
    Heller, G
    Kelly, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 417S - 417S
  • [26] Management of metastatic colorectal cancer and indications of second-line chemotherapy
    Rougier, PP
    PRESSE MEDICALE, 1996, 25 (22): : 1004 - 1005
  • [27] Treatment choices for second-line chemotherapy of metastatic breast cancer
    Zielinski, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S33 - S36
  • [28] Second-line chemotherapy with FOLFIRI in patients with metastatic gastric cancer (MGC) not previously treated with fluoropyrimidines
    Di Lauro, L.
    Fattoruso, S. I.
    Giacinti, L.
    Vici, P.
    Sergi, D.
    Lopez, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Taxane cross-resistance: An exploratory analysis of second-line chemotherapy for metastatic gastric cancer
    Di Nardo, P.
    Guardascione, M.
    Basile, D.
    Foltran, L.
    Ongaro, E.
    Miolo, G.
    Fanotto, V.
    Lisanti, C.
    Michele, B.
    Parnofiello, A.
    Cortiula, F.
    Bertoli, E.
    Buriolla, S.
    De Scordilli, M.
    Michelotti, A.
    Puglisi, F.
    Buonadonna, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S170 - S170
  • [30] SECOND-LINE DOCETAXEL (D) IN METASTATIC GASTRIC CANCER (MGC)
    Caparello, C.
    Lencioni, M.
    Vasile, E.
    Caponi, S.
    Santi, S.
    Fabrini, M. G.
    Ginocchi, L.
    Lucchesi, M.
    Ricci, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 251 - 251
12345